Literature DB >> 21651644

Expression and clinical significance of lung-specific X protein mRNA in bronchial brushing specimens from patients with or without lung cancer.

Ming Lv1, Ming-Zhe Wu, Yu-Jie Zhao, D I Yang, En-Hua Wang, Guang-Ping Wu.   

Abstract

BACKGROUND AND
OBJECTIVE: The aim of this study was to evaluate the diagnostic utility of lung-specific X protein (LUNX) mRNA expression in bronchial brushing specimens from patients with lung cancer.
METHODS: LUNX mRNA levels were assessed by performing RT-PCR on liquid-based cytology bronchial brushing specimens from patients with lung cancer (n=104) or benign lung disease (n=91).
RESULTS: LUNX mRNA expression was significantly more frequent in patients with all carcinomas, squamous cell carcinomas, adenocarcinomas, as well as patients with central, peripheral and diffuse carcinomas (P<0.01), and non-small cell lung carcinomas (P<0.05) compared with patients with benign disease. The diagnostic performance of RT-PCR analysis of LUNX mRNA was significantly better than that of cytology in terms of sensitivity (93.3±4.8% vs 64.4±9.2%), negative predictive value (91.6±6.0% vs 71.1±7.9%) and accuracy (88.7±4.4% vs 81.0±5.5%), whereas specificity (83.5±7.6%) and positive predictive value (86.6±6.3%) were lower than those of cytology (100%).
CONCLUSIONS: Liquid-based cytology and RT-PCR can be performed to detect LUNX mRNA expression in bronchial brushing specimens, and this technique may be a useful adjunct to cytological diagnosis of lung cancer. The sensitivity of the technique was greater than that of cytology but its lower specificity should be taken into account.
© 2011 The Authors. Respirology © 2011 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651644     DOI: 10.1111/j.1440-1843.2011.02008.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma.

Authors:  Hui Yu; Xiuying Huang; Zhihua Zhu; Yi Hu; Wei Ou; Lanjun Zhang; Ningning Zhou
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

2.  SPLUNC1 Is a Significant Marker in Pleural Effusion from Lung Cancer Compared to Tuberculosis.

Authors:  Jun L Xue; Ling Yi; Zhou H Yan; Xin Li; Xiao J Wang; Pang J Wei; Jiao E Zeng; Yan L Zhao; Hong T Zhang
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-06

3.  Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.

Authors:  Jing-Hua Yang; Xiao-Yan Li; Xin Wang; Wei-Jian Hou; Xue-Shan Qiu; En-Hua Wang; Guang-Ping Wu
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

4.  HPV16 E6/E7 upregulate hTERC mRNA and gene amplification levels by relieving the effect of LKB1 on Sp1 phosphorylation in lung cancer cells.

Authors:  Jing-Hua Yang; Ming-Zhe Wu; Xu-Bo Wang; Shiyu Wang; Xue-Shan Qiu; En-Hua Wang; Guang-Ping Wu
Journal:  Ther Adv Med Oncol       Date:  2020-05-12       Impact factor: 8.168

5.  Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.

Authors:  Ying Tang; Lijun Xu
Journal:  J Exp Clin Cancer Res       Date:  2013-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.